Biosergen
Biosergen is a Healthcare & Life Sciences startup based in Norway, most recent round Seed, 1 tracked investor.
About Biosergen
Biosergen is a startup based in Norway. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Biosergen is a biotech company developing novel antifungal drugs, including their lead candidate BSG005, a genetically improved polyene macrolide designed to treat invasive fungal infections in immunocompromised patients. The company originated from technology developed in collaboration with NTNU and SINTEF and has completed a Phase 1 study with ongoing proof-of-concept work.
Explore Biosergen's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.